BRZMBRPVC4MM

Applied Filters:

Keyword:'BRZMBRPVC4MM'

Showing 1-9 of 9 results for "BRZMBRPVC4MM" within Site Content

Mobius^® Breez Microbioreactor for Perfusion Process Development

The Mobius® Breez Microbioreactor is a 2 mL automated single-use perfusion system designed to support gentle, adaptable, and reproducible cell processes.

Mobius^® iFlex Bioreactors for upstream processes

Mobius® iFlex Bioreactor family offers single-use bioreactors for mammalian cell culturing from development to production.

Scalability and Performance of Mobius^® iFlex Bioreactors

This page summarizes several performance attributes and scalability data for Mobius® iFlex Bioreactors, single-use, stirred tank systems designed to support traditional and intensified fed-batch and perfusion cell culture applications.

Production and Harvest Intensification

Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.

Intensificación de la producción y de la cosecha

Los desarrolladores biofarmacéuticos necesitan procesos eficientes y productivos en las fases iniciales que proporcionen anticuerpos monoclonales de alta calidad (AcM) y otros tipos de proteínas recombinantes. La intensificación de los procesos puede preparar sus estrategias de fabricación para el futuro

Bioreactors

Learn more on mAB bioreactor production, and the products you need for this step.

Biorreactores

Obtenga más información sobre la producción en biorreactores mAB y los productos que necesita para este paso.

Accelerate development and optimization of cell culture media for upstream perfusion processes

This page describes the use of a small-scale perfusion bioreactor with integrated microfluidic flow control and sensor technologies to predict large-scale processes.

Bioprocess Considerations for Manufacturing Allogeneic Cell Therapies

This article explains how to streamline transfer of an allogeneic cell therapies process to a CDMO partner and long-term manufacturing success.